BMS settles US off-label marketing case for $19.5m
BMS illegally promoted schizophrenia drug, says attorney general
X
BMS settles US off-label marketing case for $19.5m
https://pharmaphorum.com/news/bms-settles-off-label-marketing-case-19-5m/
BMS illegally promoted schizophrenia drug, says attorney general